shutterstock_1501091933_michael_vi
Michael Vi / Shutterstock.com
17 January 2022AmericasMuireann Bolger

Genentech prevails in Baxalta haemophilia treatment suit

Genentech has gained a win in a suit claiming that its haemophilia treatment Hemlibra infringes a patent owned by Takeda subsidiary, Baxalta, after a US federal judge held that parts of the patent were invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
29 June 2021   Roche subsidiary Genentech received $209.5 million in unnecessary payments from Novartis Pharma for a patent licensing deal and is now refusing to return the payment, the Swiss pharma giant has alleged in a redacted complaint.
article
14 June 2022   Baxalta, a subsidiary of Japan-headquartered pharmaceutical company Takeda, has asked the US Court of Appeals for the Federal Circuit to overturn a decision that invalidated its antibody patent.
Big Pharma
7 March 2023   The Roche subsidiary says the licensee owes payments on “stockpile” of MS drug Tysabri.

More on this story

Big Pharma
29 June 2021   Roche subsidiary Genentech received $209.5 million in unnecessary payments from Novartis Pharma for a patent licensing deal and is now refusing to return the payment, the Swiss pharma giant has alleged in a redacted complaint.
article
14 June 2022   Baxalta, a subsidiary of Japan-headquartered pharmaceutical company Takeda, has asked the US Court of Appeals for the Federal Circuit to overturn a decision that invalidated its antibody patent.
Big Pharma
7 March 2023   The Roche subsidiary says the licensee owes payments on “stockpile” of MS drug Tysabri.

More on this story

Big Pharma
29 June 2021   Roche subsidiary Genentech received $209.5 million in unnecessary payments from Novartis Pharma for a patent licensing deal and is now refusing to return the payment, the Swiss pharma giant has alleged in a redacted complaint.
article
14 June 2022   Baxalta, a subsidiary of Japan-headquartered pharmaceutical company Takeda, has asked the US Court of Appeals for the Federal Circuit to overturn a decision that invalidated its antibody patent.
Big Pharma
7 March 2023   The Roche subsidiary says the licensee owes payments on “stockpile” of MS drug Tysabri.